Month: May 2024

Regulated Information Nyrstar NV releases notice for the 2023 annual general shareholders’ meeting to be held on 25 June 2024 24 May 2024 at 07.00 CEST Nyrstar NV (the “Company”) today issued the notice for the 2023 annual general shareholders’ meeting to be held on 25 June 2024 at 11:00 a.m. CEST. The annual general meeting will be held physically with no virtual option available. The practical modalities of the meeting are set out in the notice to the meeting which has been published on the Company’s website (https://www.nyrstarnv.be/en/investors/share-and-bondholder-information/shareholder-meetings). The full notice, including agenda, proposed resolutions and explanatory note can be found on the aforementioned Nyrstar NV website. About Nyrstar NV The Company is incorporated in Belgium and is listed on Euronext Brussels under...

Publication on May 24, 2024, at 6:30 am before market openingRegulated informationEVS Broadcast Equipment S.A.: Euronext Brussels (EVS.BR), Bloomberg (EVS BB), Reuters (EVSB.BR) EVS INVITES ITS SHAREHOLDERS TO AN EXTRAORDINARY GENERAL MEETING ON JUNE 10, 2024 As already communicated on May 21, 2024, due to the lack of attendance quorum, the Extraordinary General Meeting of EVS Broadcast Equipment SA convened on May 21, 2024 is postponed to June 10, 2024, at 12:00 pm, at its registered office in Liège, to deliberate on the agenda available on the website of the company (see link below). The Board of Directors will propose to this effect to the Shareholders to approve the issuance of warrants. The convocation and all documents relating to the General Meeting of June 10, 2024 are available on the website of EVS Broadcast Equipment at https://evs.com/en/corporate/corporate-governance/general-meetings.For...

Laurent-Perrier Group Tours-sur-Marne, 24 May 2024         Financial press releaseResults for the financial year 2023-2024 Further growth in earnings, underpinned by recognised quality The financial statements for the 2023-2024 financial year, which ended on 31 March 2024, were approved by the Management Board on 21 May 2024 and reviewed on the same day by the Supervisory Board, chaired by Mr Patrick THOMAS. The main audited consolidated financial data:In €MAt 31 March 2024 Financial year 2022-2023 (N-1)(1 April 2022 –31 March 2023) Financial year2023-2024(1 April 2023 –31 March 2024) Change vs FY N-1Champagne sales 301.8 303.5 + 0.5%Group turnover 307.8 312.5 + 1.5%Operating profit 84.9 95.1 + 12.0%Operating margin % (*) 28.1% 31.3% + 3.2 ptsNet profit – Group share 58.5 63.6 + 8.7%Earnings...

CALGARY, Alberta, May 23, 2024 (GLOBE NEWSWIRE) — Prospera Energy Inc. (“Prospera” or the “Corporation“) (TSX.V: PEI, OTC: GXRFF, FRA: OF6B, OF6B.SG, OF6B.F, OF6B.BE) provides its second bi-weekly Default Status Report under National Policy 12-203 Management Cease Trade Orders (“NP 12-203“), pursuant to which Prospera issued its original default announcement indicating that the filing of its annual audited financial statements, annual management’s discussion and analysis and related certifications for the year ended December 31, 2023 (collectively, the “Required Documents“) would be delayed beyond the filing deadline of April 29, 2024. Prospera reports that since issuing the original default announcement on April 25, 2024, there have been no material changes to the information...

TORONTO, May 23, 2024 (GLOBE NEWSWIRE) — Fairfax Financial Holdings Limited (“Fairfax”) (TSX: FFH and FFH.U) regrettably announces that Ramaswamy Athappan, Chairman and Chief Executive Officer of Fairfax Asia Limited, has passed away. Over the past 22 years, Mr. Athappan has been a driving force in developing Fairfax’s insurance operations in Southeast Asia. He made invaluable contributions to the success of Fairfax and Fairfax Asia over these years through his leadership, mentorship and guidance. “Mr. Athappan was an exceptional leader with an incredible track record of success. He was a trusted and valued colleague, but most importantly, he was a very good friend of mine and many others here at Fairfax,” said Prem Watsa, Chairman and Chief Executive Officer of Fairfax. “To his family members and loved ones, we send our deepest...

SINGAPORE and NORTH BRUNSWICK, N.J. and HANGZHOU, China, May 23, 2024 (GLOBE NEWSWIRE) — Adlai Nortye Ltd. (NASDAQ: ANL) (the “Company” or “Adlai Nortye”), a clinical-stage biotechnology company focused on the development of innovative cancer therapies, today announced that it will present encouraging preliminary data of AN0025 in combination with definitive chemoradiotherapy (dCRT) in unresectable locally advanced or locally recurrent esophageal cancer (EC) at the upcoming American Society of Cancer Oncology (ASCO) Annual Meeting to be held in Chicago from May 31 to June 4, 2024. AN0025 is a selective EP4 inhibitor that demonstrates antitumor activity by modulating the function of macrophages and immunosuppressive myeloid cells in tumor microenvironment. The combination of AN0025 with CRT as neoadjuvant therapy has shown synergistic...

HONG KONG and SHANGHAI, China and FLORHAM PARK, N.J., May 23, 2024 (GLOBE NEWSWIRE) — HUTCHMED (China) Limited (“HUTCHMED”) (Nasdaq/AIM:HCM; HKEX:13) today announces that new and updated data from several studies of compounds discovered by HUTCHMED will be presented at the upcoming American Society of Clinical Oncology (“ASCO”) Annual Meeting, taking place May 31 – June 4, 2024 in Chicago, IL and online. Results will be presented from the registration Phase II study of fruquintinib combined with sintilimab in 98 second-line or above patients with endometrial cancer (“EMC”) with pMMR status by central laboratory analysis, which supported the New Drug Application (NDA) filed in China. The primary endpoint was objective response rate (“ORR”) per RECIST v1.1, assessed by an independent review committee. The combination showed meaningful...

TORONTO, May 23, 2024 (GLOBE NEWSWIRE) — Jamieson Wellness Inc. (“Jamieson Wellness” or the “Company”) (TSX: JWEL) announced today that each of the nominee directors listed in the management information circular of the Company dated March 11, 2024 was elected as a director of the Company (a “Director”) at the annual meeting (the “Meeting”) of the holders of common shares of the Company (the “Common Shares”) held today. The number of Common Shares voted in person or by proxy for the election of each Director or withheld was as indicated below:Name of Nominee Votes For % Votes Withheld %Heather Allen 31,936,139 99.81% 60,522 0.19%Dr. Louis Aronne 31,402,494 98.14% 594,167 1.86%Tania Clarke 31,990,916 99.98% 5,745 0.02%Michael Pilato 31,965,636 99.90% 31,025 0.10%Timothy Penner 31,947,396 99.85% 49,265 0.15%Catherine...